Recently, the distributors in some regions of Yantai Dayang Pharmaceutical Co., Ltd. promoted products through informal channels, which seriously affected our company's reputation. Our company hereby solemnly declares that the "Dayang Fusheng Jinjunling Capsule" produced by our company is a Chinese medicine quasi-brand drug that has been clinically verified, not a health care product, and it is produced in strict accordance with the national GMP production management regulations. Our company requires all distributors to publicize their products through formal channels, otherwise our company will immediately suspend their distribution rights and reserve the right to resort to law.

The above is the solemn statement published by Yantai Dayang Pharmaceutical on the regulatory page of China Medical News on October 30th, 2007. All local agents are requested to restrain themselves according to law. If there is any violation, Yantai Dayang Pharmaceutical Co., Ltd. will investigate its legal responsibility.